IRIS UniCatt

Rapaccini, Gian Ludovico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.796
EU - Europa 7.938
AS - Asia 7.896
SA - Sud America 1.460
AF - Africa 209
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 18
Totale 27.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.537
SG - Singapore 3.672
DE - Germania 2.767
CN - Cina 1.923
SE - Svezia 1.381
BR - Brasile 1.194
IT - Italia 699
FR - Francia 688
VN - Vietnam 681
UA - Ucraina 594
IE - Irlanda 427
GB - Regno Unito 405
FI - Finlandia 278
IN - India 271
JP - Giappone 263
ID - Indonesia 261
RU - Federazione Russa 180
TR - Turchia 169
PL - Polonia 120
HK - Hong Kong 118
CA - Canada 115
AR - Argentina 108
BD - Bangladesh 97
IQ - Iraq 73
MX - Messico 70
NL - Olanda 65
BE - Belgio 59
KR - Corea 58
ZA - Sudafrica 58
AT - Austria 56
ES - Italia 47
EC - Ecuador 43
SA - Arabia Saudita 42
CI - Costa d'Avorio 37
MA - Marocco 32
PH - Filippine 31
CZ - Repubblica Ceca 30
PK - Pakistan 30
VE - Venezuela 29
LT - Lituania 25
UZ - Uzbekistan 25
CH - Svizzera 23
CO - Colombia 22
AE - Emirati Arabi Uniti 21
IR - Iran 21
RO - Romania 19
EG - Egitto 18
KE - Kenya 18
CL - Cile 17
JO - Giordania 17
EU - Europa 16
BZ - Belize 14
AU - Australia 13
AZ - Azerbaigian 13
PE - Perù 13
BG - Bulgaria 12
IL - Israele 12
PY - Paraguay 12
TW - Taiwan 12
UY - Uruguay 12
JM - Giamaica 11
NP - Nepal 11
PT - Portogallo 11
DZ - Algeria 10
KZ - Kazakistan 9
PA - Panama 9
TT - Trinidad e Tobago 9
GR - Grecia 8
HU - Ungheria 8
KG - Kirghizistan 8
LB - Libano 8
TN - Tunisia 8
ET - Etiopia 7
CR - Costa Rica 6
HN - Honduras 6
LK - Sri Lanka 6
MY - Malesia 6
OM - Oman 6
BO - Bolivia 5
BY - Bielorussia 5
CG - Congo 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GE - Georgia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
AL - Albania 4
MD - Moldavia 4
SC - Seychelles 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
GY - Guiana 3
KW - Kuwait 3
MK - Macedonia 3
NG - Nigeria 3
NO - Norvegia 3
SI - Slovenia 3
TH - Thailandia 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 27.295
Salva come PNG Salva come JPEG
Città #
Singapore 2.036
Chandler 1.208
Ashburn 1.078
San Jose 871
Dublin 425
Dallas 395
New York 389
Beijing 331
Jacksonville 324
Los Angeles 254
San Mateo 250
Ho Chi Minh City 246
Tokyo 241
Jakarta 234
Nanjing 231
Hefei 228
Lauterbourg 217
Ann Arbor 163
Nürnberg 162
Boston 160
Wilmington 160
Hanoi 155
Frankfurt am Main 144
Houston 142
Dearborn 139
Munich 135
Helsinki 128
The Dalles 128
Princeton 125
Chicago 123
Milan 119
Moscow 113
Rome 109
São Paulo 104
Izmir 103
Marseille 100
Hong Kong 97
Cattolica 87
Woodbridge 79
Buffalo 71
Seattle 71
Santa Clara 70
Nanchang 69
Kent 67
Bremen 61
Redwood City 61
Redmond 60
Brussels 55
Paris 55
Fairfield 53
Seoul 53
Kraków 52
Boardman 48
Warsaw 48
Shenyang 47
London 46
Da Nang 44
Council Bluffs 42
Lawrence 41
Nuremberg 41
Brooklyn 38
Guangzhou 38
Hebei 38
Rio de Janeiro 38
Abidjan 37
Denver 37
Tianjin 37
Chennai 36
Hangzhou 36
Lancaster 36
Shanghai 36
Stockholm 36
Hyderabad 35
Belo Horizonte 34
Mountain View 34
Orem 34
Phoenix 34
Montreal 33
Norwalk 33
Zhengzhou 33
Toronto 32
Atlanta 31
Vienna 31
Kunming 30
Pune 30
Amsterdam 29
Baghdad 29
University Park 29
Changsha 28
Johannesburg 28
Poplar 28
Turku 27
Augusta 26
Manchester 26
San Francisco 25
Brasília 24
Haiphong 24
Leawood 24
Bologna 23
Jiaxing 23
Totale 14.148
Salva come PNG Salva come JPEG
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 455
Association between Klinefelter syndrome and focal nodular hyperplasia 338
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 263
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 242
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 242
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 236
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 236
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 228
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 224
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 218
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 206
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 203
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 200
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 199
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 197
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 190
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 190
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 188
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 188
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 186
Liver transplantation in patients with alcoholic liver disease: A retrospective study 186
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 181
recurrent acute hepatitis associated with use of cetrizine 180
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 178
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 177
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 175
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 174
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 173
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 173
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 173
Potential use of liver function breath tests in the clinical practice. 172
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 168
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 165
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 163
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 158
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 157
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 156
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 156
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 156
Development and validation of predictive assessment of complicated diverticulitis score 154
Sarilumab use in severe SARS-CoV-2 pneumonia 153
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 152
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 152
Immunological role of IgG subclasses 150
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 149
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 148
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 146
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 146
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 146
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 146
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 146
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 145
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 141
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 141
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 140
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 140
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 140
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 139
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 139
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 139
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 139
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (< 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging 139
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 138
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 137
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 137
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 136
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 135
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 135
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 134
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 133
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 133
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 133
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 133
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 132
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 132
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 131
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 131
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 131
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 131
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 130
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 130
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 130
[Liver transplantation] 128
Acute hepatitis associated with use of paroxetine 127
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 127
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 127
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 126
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 126
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 126
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 125
The role of elastography in non-Alcoholic fatty liver disease 125
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt 124
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation 124
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 124
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 124
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 124
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 123
Totale 16.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021356 0 0 0 0 0 0 0 0 0 58 260 38
2021/20221.642 110 118 39 140 102 54 34 221 66 107 283 368
2022/20233.728 476 436 268 501 295 431 226 314 444 97 163 77
2023/20242.063 114 554 64 135 80 353 113 88 26 125 160 251
2024/20254.010 108 107 377 117 344 166 107 220 579 354 848 683
2025/20269.994 1.520 289 919 1.303 1.829 546 1.786 510 658 634 0 0
Totale 27.691